AKT1 and chronic obstructive pulmonary disease: Bronchial epithelial cells from patients with COPD have increased production of CXCL8 and increased phosphorylation of EGFR and AKT; however, all were reduced in vitro with erlotinib, a clinical EGFR inhibitor (48).